ArticleCancer medicine2018

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

Anna Coppa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.